Derivation and validation of the incomplete ST-segment resolution score and its usefulness for treatment with glycoprotein IIb-IIIa inhibitors-Reference-Cited by-同舟云学术

Derivation and validation of the incomplete ST-segment resolution score and its usefulness for treatment with glycoprotein IIb-IIIa inhibitors

Published:2023-12-22 Issue:2 Volume:25 Page:173-175
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:

Author:

Cornara Stefano¹²,Mandurino-Mirizzi Alessandro¹³,Somaschini Alberto¹²,Mauri Silvia¹⁴,Crimi Gabriele⁵,Munafò Andrea¹⁶,Camporotondo Rita⁶,Gnecchi Massimiliano¹⁷,De Servi Stefano¹,De Ferrari Gaetano Maria⁸,Ferlini Marco⁶

Affiliation:

1. Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Pavia

2. Cardiac Intensive Care Unit, Division of Cardiology, San Paolo Hospital, Savona

3. Division of Cardiology, “V. Fazzi” Hospital, 73100 Lecce

4. Cardiology and Coronary Unit, ASST Ovest Milanese, Milan

5. Interventional Cardiology Unit, CardioThoraco Vascular Department (DICATOV), IRCCS Ospedale Policlinico San Martino, Genova

6. Division of Cardiology

7. Cardiolgia Traslazionale, Fondazione IRCCS Policlinico San Matteo, Pavia

8. Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza Hospital, Turin, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference10 articles.

1. Prognostic implications of ST-segment elevation resolution in patients with ST-segment elevation acute myocardial infarction treated with primary or facilitated percutaneous coronary intervention;Palmerini;Am J Cardiol,2010

2. Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution;Somaschini;Platelets,2020

3. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial: ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group;Van’t Hof;Lancet,2008

4. Impact of glycoprotein IIb/IIIa in contemporary percutaneous coronary intervention for acute coronary syndromes. Insight from the national cardiovascular data registry;Safley;J Am Coll Cardiol Interv,2015

5. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC);Ibanez;Eur Heart J,2017